Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Q4 2024 Earnings Call Transcript March 27, 2025 Acumen Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is ...

Gary Romano, M.D., Ph.D., to transition from Chief Medical Officer role-- SOUTH SAN FRANCISCO, Calif., March 28, 2025 (GLOBE NEWSWIRE) -- ...

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

Final phase 2a results showed that CAN-2409 led to a median overall survival of 24.5 months in immune checkpoint ...

The complete response letter, issued by the FDA, does not identify what deficiencies regulators found in ...

LifeTech Scientific Corporation (the 'Company' or 'LifeTech', Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and ...

Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...